Keith Reeves

R. Keith Reeves, Ph.D.

R. Keith Reeves, Ph.D.

Principal Investigator and Adjunct

Professor and Director, Duke University Center for Human Systems Immunology

Adjunct Professor, Center for Virology and Vaccine Research

keith.reeves@duke.edu

Education

  • MS State University, Starkville, MS, B.S., 2002 (Microbiology)
  • University of Alabama Medical School, Birmingham, AL, Ph.D., 2007 (Virology)

Training

  • 2007-2014, Postdoctoral Research Fellow in Medicine, New England Primate Research Center, Harvard Medical School

Appointments

  • 2011 – 2013, Instructor in Medicine, Harvard Medical School, NEPRC
  • 2013, Instructor in Medicine, Beth Israel Deaconess Medical Center
  • 2013 –  present, Adjunct Assistant Professor, Department of Pathology, Emory University
  • 2014 – 2021, Assistant Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center
  • 2021 – present, Professor of Surgery, Duke University School of Medicine
  • 2021 – present, Professor of Pathology, Duke University School of Medicine
  • 2021 – present, Director, Center for Human Systems Immunology, Duke University School of Medicine
  • 2021 – present, Adjunct Professor, Center for Virology and Vaccine Research

Honors

  • 2000, H. H. Harned Memorial Award/Scholarship for Most Outstanding Undergraduate Student in Microbiology, MSU
  • 2002-2003, E. B. Carmichael Scholar – One chosen annually from all University of Alabama at Birmingham graduate students in biomedical disciplines
  • 2003-2007, NIH Predoctoral Fellowship – Basic Mechanisms in Virology
  • 2006, Raymond N. Hiramoto Award in Microbiology, University of Alabama at Birmingham
  • 2008, Early Career Investigator, OCTAVE Mucosal Immunity and Vaccine Design, Cape Town, South Africa
  • 2008, Young Investigator Award, 26th Annual Nonhuman Primate Models for AIDS Symposium, San Juan, Puerto Rico
  • 2009, Early Stage Investigator Award, CHAVI/HVTN
  • 2009, Young Investigator Award, 16th Annual Conference on Retroviruses and Opportunistic Infections, Montreal, Quebec, CAN
  • 2009, Keystone Symposia Scholarship, Prevention of HIV/AIDS, Keystone, Colorado
  • 2010, Young Investigator Award, 17th Annual Conference on Retroviruses and Opportunistic Infections, San Francisco, CA
  • 2011, Early Stage Investigator Award, CHAVI/HVTN
  • 2011, Conference Scholarship, AIDS Vaccine, Bangkok, Thailand
  • 2012, Early Career Grant, AAI

Publications

  • Ram DR, Gopalakrishnan RM, Aid M, Kroll K, Miftahof J, Aristizabal O, Gikundiro EK, Davis C, Hefti MM, Fiock KL, Tilahun B, Umutoniwase Y, Loidolt K, Fennessey CM, Mercado NB, Harper-Alexander V, Jones R, Woolley G, Varner V, Lifton M, Bosinger SE, Barouch DH, Keele BF, Reeves RK, Tan CS. Anti-IL-15 treatment reduces acute lentivirus inflammation and signaling in the brain. Cell Rep Med. 2026 Jan 20;7(1):102567. doi: 10.1016/j.xcrm.2025.102567 [Article]

  • Terry K, Kroll KW, Jones RA, Reeves RK. Application of a novel branched-DNA assay to quantify killer immunoglobulin-like receptor (KIR) mRNA expression identifies tissue compartmentalization in naïve and SIV-infected rhesus macaques. J Immunol Methods. 2026 Jan;546:114022. doi: 10.1016/j.jim.2025.114022. Epub 2025 Dec 20. PMID: 41429386; PMCID: PMC12840321. [Article]

  • Manickam C, Jones R, Deb Adhikary NR, Kroll KW, Terry K, Balachandran H, Woolley G, Tomaras GD, Villinger FJ, Reeves RK. Myeloid cell recruitment and activation through systemic and mucosae-directed cytokine therapy. Immunol Cell Biol. 2025 Nov-Dec;103(10):945-956. doi: 10.1111/imcb.70061. Epub 2025 Oct 7. PMID: 41054306; PMCID: PMC12667110. [Article]

  • Kroll KW, Woolley G, Reeves RK. Building a better natural killer (NK) cell: Fc receptor engineering strategies for NK cell therapeutics. Future Virol. 2025 Oct;20(10):369-371. doi: 10.1080/17460794.2025.2580187. Epub 2025 Oct 29. PMID: 41409329; PMCID: PMC12707376. [Article]

  • Jones R, Afifi A, Reeves RK, Manickam C. Functional Reprogramming of Peripheral Eosinophils in Lentivirus-Infected Rhesus Macaques. AIDS Research and Human Retroviruses. 2025 Aug;41(8):411-413. doi: 10.1089/aid.2024.0105. Epub 2025 Jun 10. [Article]

  • Mahyari, E., Boggy, G. J., McElfresh, G. W., Kaza, M., Benjamin, S., Varco-Merth, B., Ojha, S., Feltham, S., Goodwin, W., Nkoy, C., Duell, D., Selseth, A., Bennett, T., Barber-Axthelm, A., Smedley, J. V., Labriola, C. S., Axthelm, M. K., Reeves, R. K., Okoye, A. A., Hansen, S. G., … Bimber, B. N. (2025). Enhanced interpretation of immune cell phenotype and function through a rhesus macaque single-cell atlas. Cell genomics5(5), 100849. https://doi.org/10.1016/j.xgen.2025.100849 [Article]

  • Blass, E., Colarusso, A., Aid, M., Larocca, R. A., Reeves, R. K., & Barouch, D. H. (2025). Early spatiotemporal evolution of the immune response elicited by adenovirus serotype 26 vector vaccination in mice. Journal of virology99(5), e0024725. https://doi.org/10.1128/jvi.00247-25 [Article]

  • Hudson, A., Wu, P., Kroll, K. W., Hueber, B., Woolley, G., Shi, P., & Reeves, R. K. (2025). Longitudinal analysis of rhesus macaque metabolome during acute SIV infection reveals disruption in broad metabolite classes. Journal of virology99(3), e0163424. https://doi.org/10.1128/jvi.01634-24 [Article]

  • Nohara J, Evangelous T, Berry M, Beck W, Mudrak S, Jha S, Reeves RK, Wiehe KJ, Pollara J, Tomaras GD, Bradley T, Ferrari G. Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity. Pathog Immun. 2025 Jan 23;10(1):49-79. doi: 10.20411/pai.v10i1.734. [Article]

  • Nohara J, Evangelous T, Berry M, Beck W, Mudrak S, Jha S, Reeves RK, Wiehe KJ, Pollara J, Tomaras GD, Bradley T, Ferrari G. Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity. Pathog Immun. 2025 Jan 23;10(1):49-79. doi: 10.20411/pai.v10i1.734. PMID: 39911143; PMCID: PMC11792536. [Article]